Amotiv Limited Cash Flow Conversion Efficiency

Latest as of December 2025: 0.090x

Amotiv Limited cash flow conversion efficiency. Based on the latest financial reports, Amotiv Limited (AOV) has a cash flow conversion efficiency ratio of 0.090x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$68.96 Million ≈ $49.88 Million USD) by net assets (CA$767.27 Million ≈ $555.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Amotiv Limited (2014–2025)

Cash flow conversion efficiency of Amotiv Limited from 2014 to 2025. This chart illustrates how Amotiv Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View AOV stock price for real-time trading data and today's change.

Amotiv Limited Cash Flow Conversion Ratio Explained

Amotiv Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Amotiv Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Amotiv Limited ranked by their cash flow conversion efficiency. Also see market value of Amotiv Limited for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Flytech Technology Co Ltd
TW:6206
-0.034x
First Hi-tec Enterprise Co Ltd
TWO:5439
0.178x
LG Balakrishnan & Bros Limited
NSE:LGBBROSLTD
0.063x
Limbach Holdings Inc
NASDAQ:LMB
0.092x
Autohellas S.A.
AT:OTOEL
0.064x
Great Lakes Dredge & Dock
NASDAQ:GLDD
0.098x
Voltalia SA
PA:VLTSA
0.078x
COFCO Engineering & Technology Co Ltd
SHE:301058
0.015x

Annual Cash Flow Conversion Efficiency for Amotiv Limited (2014–2025)

The table below shows the annual cash flow conversion efficiency of Amotiv Limited from 2014 to 2025. Review how much free cash does Amotiv Limited generate to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$767.27 Million
≈ $555.03 Million
CA$68.96 Million
≈ $49.88 Million
0.090x +96.96%
2024-12-31 CA$795.11 Million
≈ $575.17 Million
CA$36.28 Million
≈ $26.24 Million
0.046x -5.18%
2023-12-31 CA$746.87 Million
≈ $540.28 Million
CA$35.94 Million
≈ $26.00 Million
0.048x -1.83%
2022-12-31 CA$825.86 Million
≈ $597.41 Million
CA$40.48 Million
≈ $29.28 Million
0.049x -7.50%
2021-12-31 CA$842.02 Million
≈ $609.10 Million
CA$44.62 Million
≈ $32.28 Million
0.053x +484.77%
2020-12-31 CA$886.24 Million
≈ $641.09 Million
CA$-12.21 Million
≈ $-8.83 Million
-0.014x -374.21%
2019-12-31 CA$915.11 Million
≈ $661.97 Million
CA$4.60 Million
≈ $3.32 Million
0.005x +190.14%
2018-12-31 CA$1.03 Billion
≈ $745.11 Million
CA$-5.74 Million
≈ $-4.15 Million
-0.006x -123.54%
2017-12-31 CA$991.21 Million
≈ $717.02 Million
CA$23.46 Million
≈ $16.97 Million
0.024x +57.32%
2016-12-31 CA$979.72 Million
≈ $708.71 Million
CA$14.74 Million
≈ $10.66 Million
0.015x +26.49%
2015-12-31 CA$642.06 Million
≈ $464.46 Million
CA$7.64 Million
≈ $5.52 Million
0.012x +609.11%
2014-12-31 CA$478.99 Million
≈ $346.49 Million
CA$803.34K
≈ $581.13K
0.002x --

About Amotiv Limited

TO:AOV Canada Drug Manufacturers - Specialty & Generic
Market Cap
$826.47 Million
CA$1.14 Billion CAD
Market Cap Rank
#11137 Global
#331 in Canada
Share Price
CA$11.27
Change (1 day)
-1.14%
52-Week Range
CA$5.76 - CA$11.70
All Time High
CA$11.70
About

Knight Therapeutics Inc. develops, manufactures, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices worldwide. It offers Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib for metastatic cholangiocarcinoma; Akynzeo for prevention of chemotherapy-induced acute and delayed nausea and vomiting;… Read more